Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psyllium for Fructan Sensitivity in Children With IBS
NCT06639984Phase 2Recruiting
- Start
- Feb 2025
- Primary completion
- Sep 2027
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of psyllium husks in irritable bowel syndrome (IBS) (3 arms). Primary endpoints: Change in microbiome composition at 2 weeks, Change in fecal lactate at 2 weeks and 3 more. Started Feb 2025; status: recruiting.
02
Drugs
psyllium husks
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT06639984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06639984.